Novartis Oncology
-
Yardley-Based Jubilant Therapeutics Appoints Industry Veteran as New CEO
Jubilant Therapeutics, a Yardley-based biopharmaceutical company focused on cancer and autoimmune disease treatments, has named Daniel J. O’Connor to be…
-
King of Prussia’s Qlik Prepares for Second IPO with Series of Acquisitions
King of Prussia-based Qlik is preparing to offer another IPO opportunity after recently boosting its product line through acquisition, writes…
Founding Partners
Advertisement
Affiliate Partners
Community Partners
